Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Watch
Primary summary from verified readiness
- Confidence
- 64% · fresh
- Computed at
- 2026-07-23T19:13:02.904942+00:00
- Claimed
- 60
- Reported
- 59
- Verified
- 53
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-07-23
Track; not yet
- Why
- esmGFP is a genuine category-defining generative-design proof point (~500M simulated evolutionary years from a functional novel protein), but the company's own materials put real therapeutic payoff up to a decade out and flagship access remains closed-beta / non-commercial.
- Next
- Re-evaluate when EvolutionaryScale opens commercial licensing for the 98B flagship model, or when a documented drug/material asset traces back to an ESM3-designed protein reaching clinical or commercial stage.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 2
- Tier 3
- 5
- Supports
- 3
- Contradicts
- 2
- Context
- 2
- Latest observed
- 2026-07-23
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-23 Reading moved from watch to watch.